XNCR Q3 2019 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M-25.1% YoY

Gross Profit

-$8M-36.8% margin

Operating Income

-$14M-65.6% margin

Net Income

-$10M-47.0% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+11.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$10M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$686M

Total Liabilities

$76M

Stockholders' Equity

$610M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$29M	-25.1%
Gross Profit	-$8M	$8M	-199.1%
Operating Income	-$14M	$651,000	-2292.9%
Net Income	-$10M	$3M	-424.6%

Revenue Segments

Milestone

$19M89%

Royalty

$1M6%

Collaboration

$600,0003%

License

$500,0002%